Inside the mRNA Revolution Beyond COVID: Cancer Vaccines and Rare Disease Treatments

mRNA technology pioneered by BioNTech and Moderna for COVID vaccines is now targeting cancer and rare diseases. Personalized cancer vaccines enter Phase III trials. mRNA therapeutics for rare genetic disorders showing promise. The platform approach: same delivery technology (lipid nanoparticles), different mRNA payload. Challenges include delivery to specific organs and manufacturing scalability. If successful, mRNA could become a universal therapeutic platform.